Evidence map›Paper›PMID 34294589›Full record

ArticleSurgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery2021

Postbariatric hypoglycemia: symptom patterns and associated risk factors in the Longitudinal Assessment of Bariatric Surgery study.

Laura E Fischer, Bruce M Wolfe, Nora Fino, Miriam R Elman, David R Flum, James E Mitchell, Alfons Pomp, Walter J Pories, Jonathan Q Purnell, Mary-Elizabeth Patti and 1 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 2 countries.

Laura E FischerDepartment of Surgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma. Electronic address: laura-fischer@ouhsc.edu.
Bruce M WolfeDepartments of Medicine, Surgery, and the School of Public Health at Oregon Health & Science University, Portland, Oregon.
Nora FinoDepartments of Medicine, Surgery, and the School of Public Health at Oregon Health & Science University, Portland, Oregon.
Miriam R ElmanOregon Health and Science - Portland State University School of Public Health, Portland, Oregon.
David R FlumDepartment of Surgery, University of Washington, Seattle, Washington.
James E MitchellDepartment of Psychiatry and Behavioral Science, University of North Dakota School of Medicine, Grand Forks, North Dakota.
Alfons PompDepartment of Surgery, University of Montreal, Montreal, Quebec, Canada.
Walter J PoriesMetabolic Surgery Research Group, East Carolina University, Greenville, North Carolina.
Jonathan Q PurnellDepartments of Medicine, Surgery, and the School of Public Health at Oregon Health & Science University, Portland, Oregon.
Mary-Elizabeth PattiResearch Division, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts.
LABS Investigators
Oregon Health & Science University · USJoslin Diabetes Center · USEast Carolina University · USUniversité de Montréal · CAUniversity of North Dakota · USUniversity of Washington · USPortland State University · USUniversity of Oklahoma Health Sciences Center · US

Funding

UNIVERSITY OF PITTSBURGH CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE: BPCAUL1RR024153 · NCRR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2006 to 2011
$73.9M
SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI JEAN E. SCHAFFER · 1986 to 2026
$50.5M
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR024996 · NCRR · WEILL MEDICAL COLL OF CORNELL UNIV · PI IMPERATO-MCGINLEY, JULIANNE L · 2007 to 2011
$49.6M
ZIPRASIDONE IN NORMAL HEPATIC FUNCTION SUBJECTS &IN HEPATIC DYSFUCTIN SUBJECTSM01RR000037 · NCRR · UNIVERSITY OF WASHINGTON · PI PARK, JULIE R · 1985 to 2007
$33.8M
Continuation of the Longitudinal Assessment of Bariatric Surgery (LABS) - DCCU01DK066557 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BELLE, STEVEN H. · 2003 to 2015
$15.8M
Alliance of Randomized Trials of Medicine vs Metabolic Surgery in Type 2 Diabetes - (ARMMS-T2D)U01DK114156 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI AMINIAN, ALI, KIRWAN, JOHN P. · 2017 to 2022
$8.9M
BARIATRIC SURGERY CLINICAL RESEARCH CONSORTIUMU01DK066555 · NIDDK · UNIVERSITY OF CALIFORNIA DAVIS · PI WOLFE, BRUCE M · 2003 to 2013
$6.2M
Effect of Bariatric Surgery on Insulin Resistance &CVDU01DK066585 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI COURCOULAS, ANITA P · 2003 to 2013
$5.0M
Bariatric Surgery: Outcomes & Impact on PathophysiologyU01DK066667 · NIDDK · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI BERK, PAUL DAVID, POMP, ALFONS · 2003 to 2015
$4.7M
Longtitudinal Assessment of Bariatric Surgery (LABS)U01DK066568 · NIDDK · UNIVERSITY OF WASHINGTON · PI FLUM, DAVID R · 2003 to 2013
$4.3M
Paternal Contributions to Metabolic Disease in Offspring: Environment, Epigenetics, and SpermR01DK106193 · NIDDK · JOSLIN DIABETES CENTER · PI PATTI, MARY E · 2016 to 2024
$4.3M
East Carolina University Bariatric Surgery Clinical CenterU01DK066526 · NIDDK · EAST CAROLINA UNIVERSITY · PI PORIES, WALTER JULIUS · 2003 to 2015
$4.0M
NCRR NIH HHS M01 RR000037NCRR NIH HHS UL1 RR024153NCRR NIH HHS UL1 RR024996NIDDK NIH HHS P30 DK036836NIDDK NIH HHS R01 DK103842NIDDK NIH HHS R01 DK106193NIDDK NIH HHS R01 DK121995NIDDK NIH HHS U01 DK066471NIDDK NIH HHS U01 DK066526NIDDK NIH HHS U01 DK066555NIDDK NIH HHS U01 DK066557NIDDK NIH HHS U01 DK066568NIDDK NIH HHS U01 DK066585NIDDK NIH HHS U01 DK066667NIDDK NIH HHS U01 DK114156
6 · The paper itself

Abstract

backgroundPostbariatric hypoglycemia (PBH) can be a devastating complication for which current therapies are often incompletely effective. More information is needed regarding frequency, incidence, and risk factors for PBH.

objectivesTo examine hypoglycemia symptoms following Roux-en-Y gastric bypass (RYGB) and laparoscopic adjustable gastric banding (LAGB) and baseline and in-study risk factors.

settingMulticenter, at 10 US hospitals in 6 geographically diverse clinical centers.

methodsA prospective, longitudinal cohort study of adults undergoing RYGB or LAGB as part of clinical care between 2006 and 2009 were recruited and followed until January 31, 2015, with baseline and annual postoperative research assessments. We analyzed baseline prevalence and post-operative incidence and frequency of self-reported hypoglycemia symptoms as well as potential preoperative risk factors.

resultsIn all groups, postoperative prevalence of hypoglycemia symptoms was 38.5%. Symptom prevalence increased postoperatively from 2.8%-36.4% after RYGB in patients without preoperative diabetes (T2D), with similar patterns in prediabetes (4.9%-29.1%). Individuals with T2D had higher baseline hypoglycemia symptoms (28.9%), increasing after RYGB (57.9%). Hypoglycemia symptoms were lower after LAGB, with 39.1% reported hypoglycemia symptoms at only 1 postoperative visit with few (4.0%) having persistent symptoms at 6 or more annual visits. Timing of symptoms was not restricted to the postprandial state. Symptoms of severe hypoglycemia were reported in 2.6-3.6% after RYGB. The dominant risk factor for postoperative symptoms was preoperative symptoms; additionally, baseline selective serotonin (SSRI) and serotonin-norepinephrine (SNRI) reuptake inhibitor use was also associated with increased risk in multivariable analysis. Weight loss and regain were not related to hypoglycemia symptom reporting.

conclusionHypoglycemia symptoms increase over time after RYGB, particularly in patients without diabetes. In a small percentage, symptoms can be persistent or severe and require hospitalization. Preoperative hypoglycemia symptoms and SSRI/SNRI use in RYGB patients without diabetes is associated with increased risk of symptoms.

Indexed as

Bariatric SurgeryGastric BypassHypoglycemiaObesity, MorbidAdultHumansLongitudinal StudiesProspective StudiesRisk FactorsTreatment OutcomeBariatric surgeryDiabetesHypoglycemiaLaparoscopic adjustable gastric bandRoux-en-Y gastric bypassSNRISSRI

Identifiers

PMID34294589
PMCPMC9944569
OpenAlexW3163554007

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.